T-plastin (PLS3 ) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression-Reference-Cited by-同舟云学术

T-plastin (PLS3 ) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression

Published:2009-11-30 Issue:2 Volume:162 Page:463-466
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Tang N.,Gibson H.,Germeroth T.,Porcu P.,Lim H.W.,Wong H.K.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2009.09587.x/fullpdf

Reference10 articles.

1. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group;Harris;Blood,1994

2. Treatment planning in cutaneous T-cell lymphoma;Vonderheid;Dermatol Ther,2003

3. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides;Chong;Clin Cancer Res,2008

4. The current state and future of clonality studies in mycosis fungoides;Jones;J Invest Dermatol,2003

5. Aberrant expression of T-plastin in Sézary cells;Su;Cancer Res,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma;Frontiers in Oncology;2021-06-24

2. Plastin 3 in health and disease: a matter of balance;Cellular and Molecular Life Sciences;2021-05-23

3. The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort*;British Journal of Dermatology;2021-03-10

4. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome;Cells;2020-08-29

5. Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma;Frontiers in Oncology;2020-02-07